Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 201612-61-5
2. Sodium;(113c)octanoate
3. Sodium Caprylate, 1-c-13
4. Sodium Octanoate C-13, 1-
5. Sodium Octanoate-1-(sup 13)c
6. Sodium Octanoate C-13
7. Octanoate-13c (sodium)
8. K216hq0ffu
9. Unii-k216hq0ffu
10. Sodium Caprylate-1-13c
11. Schembl1332721
12. Bia61261
13. Hy-w015339s
14. Mfcd00084072
15. Cs-0375785
16. J-013079
17. Q27281840
Molecular Weight | 167.19 g/mol |
---|---|
Molecular Formula | C8H15NaO2 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 2 |
Rotatable Bond Count | 6 |
Exact Mass | 167.10032883 g/mol |
Monoisotopic Mass | 167.10032883 g/mol |
Topological Polar Surface Area | 40.1 Ų |
Heavy Atom Count | 11 |
Formal Charge | 0 |
Complexity | 94.1 |
Isotope Atom Count | 1 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
ABOUT THIS PAGE
A Sodium Octanoate-1-13C manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Sodium Octanoate-1-13C, including repackagers and relabelers. The FDA regulates Sodium Octanoate-1-13C manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Sodium Octanoate-1-13C API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Sodium Octanoate-1-13C supplier is an individual or a company that provides Sodium Octanoate-1-13C active pharmaceutical ingredient (API) or Sodium Octanoate-1-13C finished formulations upon request. The Sodium Octanoate-1-13C suppliers may include Sodium Octanoate-1-13C API manufacturers, exporters, distributors and traders.
click here to find a list of Sodium Octanoate-1-13C suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Sodium Octanoate-1-13C DMF (Drug Master File) is a document detailing the whole manufacturing process of Sodium Octanoate-1-13C active pharmaceutical ingredient (API) in detail. Different forms of Sodium Octanoate-1-13C DMFs exist exist since differing nations have different regulations, such as Sodium Octanoate-1-13C USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Sodium Octanoate-1-13C DMF submitted to regulatory agencies in the US is known as a USDMF. Sodium Octanoate-1-13C USDMF includes data on Sodium Octanoate-1-13C's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Sodium Octanoate-1-13C USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Sodium Octanoate-1-13C suppliers with USDMF on PharmaCompass.
Sodium Octanoate-1-13C Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Sodium Octanoate-1-13C GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Sodium Octanoate-1-13C GMP manufacturer or Sodium Octanoate-1-13C GMP API supplier for your needs.
A Sodium Octanoate-1-13C CoA (Certificate of Analysis) is a formal document that attests to Sodium Octanoate-1-13C's compliance with Sodium Octanoate-1-13C specifications and serves as a tool for batch-level quality control.
Sodium Octanoate-1-13C CoA mostly includes findings from lab analyses of a specific batch. For each Sodium Octanoate-1-13C CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Sodium Octanoate-1-13C may be tested according to a variety of international standards, such as European Pharmacopoeia (Sodium Octanoate-1-13C EP), Sodium Octanoate-1-13C JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Sodium Octanoate-1-13C USP).
LOOKING FOR A SUPPLIER?